AI & ChatGPT searches , social queriess for EPTINEZUMAB
Search references for EPTINEZUMAB. Phrases containing EPTINEZUMAB
See searches and references containing EPTINEZUMAB!
Search references for EPTINEZUMAB. Phrases containing EPTINEZUMAB
See searches and references containing EPTINEZUMAB!EPTINEZUMAB
Monoclonal antibody
Eptinezumab, sold under the brand name Vyepti, is a medication used for the preventive treatment of migraine in adults. It is a monoclonal antibody that
Eptinezumab
Class of drugs
SB-268262 Erenumab (AMG-334) is approved for prevention of migraine. Eptinezumab (ALD403) is approved for prevention of migraine. Fremanezumab (TEV-48125)
Calcitonin gene-related peptide receptor antagonist
Calcitonin_gene-related_peptide_receptor_antagonist
Antibodies from clones of the same blood cell
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Monoclonal_antibody
Monoclonal antibody
Spreitzer H (3 July 2017). "Neue Wirkstoffe: Galcanezumab, Fremanezumab und Eptinezumab". Österreichische Apothekerzeitung (in German) (14/2017). "Drug Approval
Galcanezumab
Pharmaceutical compound
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Devextinetug
Combination medication
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Meloxicam/rizatriptan
Medication
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Concizumab
Disorder resulting in recurrent moderate–severe headaches
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Migraine
Medication for acute migraine in adults
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Rimegepant
Pharmaceutical drug
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Romosozumab
Monoclonal antibody against amyloid beta
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Lecanemab
Investigational antimigraine drugs
acetylcholine release inhibitor and neuromuscular blocking agent – migraine [2] Eptinezumab (ALD-403; Lu-AG09221; Vyepti) – monoclonal antibody against calcitonin
List of investigational headache and migraine drugs
List_of_investigational_headache_and_migraine_drugs
Drug class
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Anti-amyloid_antibodies
Monoclonal antibody against amyloid beta
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Donanemab
Antibodies from non-human species made nearly identical with human ones
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Humanized_antibody
Experimental monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Prasinezumab
Alpha-adrenergic agonist
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Clonidine
Pharmaceutical drug
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Evolocumab
Peptide hormone in animals
medication manufactured by AbbVie. Also FDA approved in February 2020, eptinezumab (Vyepti), is an intravenous migraine prophylactic medication manufactured
Calcitonin gene-related peptide
Calcitonin_gene-related_peptide
Pharmaceutical drug classification
N02CD02 Galcanezumab N02CD03 Fremanezumab N02CD04 Ubrogepant N02CD05 Eptinezumab N02CD06 Rimegepant N02CD07 Atogepant N02CD08 Zavegepant N02CX01 Pizotifen
ATC_code_N02
Chemical compound
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Bimagrumab
Drug class
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Ditan
Cell surface receptors
MK-3207 Olcegepant Rimegepant SB-268262 Telcagepant Ubrogepant Antibodies Eptinezumab Erenumab Fremanezumab Galcanezumab Agonists Cholecystokinin Antagonists
Signaling_peptide_receptor
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Emicizumab
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Atogepant
Medication for treatment of migraine
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Zavegepant
Medication for migraine headache acute treatment
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Ubrogepant
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Management of chronic headaches
Management_of_chronic_headaches
Medication
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Bevacizumab
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Tadocizumab
from the original on 15 July 2020. Retrieved 23 January 2020. "Vyepti- eptinezumab-jjmr injection". DailyMed. Archived from the original on 28 September
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
Methods to reduce the frequency and severity of migraine attacks
Medications in the anti-calcitonin gene-related peptide, including eptinezumab, erenumab, fremanezumab, and galcanezumab, appear to decrease the frequency
Prevention of migraine attacks
Prevention_of_migraine_attacks
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Olcegepant
Pharmaceutical biological monoclonal antibody
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Fremanezumab
Drugs that inhibit α-synuclein
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Anti-α-synuclein_drug
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Bedinvetmab
Medication used to treat epilepsy and migraine
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Topiramate
Pharmaceutical drug
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Alirocumab
Monoclonal antibody against amyloid beta
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Aducanumab
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Naratriptan
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Opicinumab
Medication
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Marstacimab
Chemical compound
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Ascrinvacumab
Chemical compound
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Bapineuzumab
Pharmaceutical product
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Ergotamine/caffeine
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Erenumab
Medication used for migraines & cluster headaches
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Sumatriptan
Pharmaceutical compound
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Abciximab
Human monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Denosumab
Chemical compound
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Caplacizumab
Medication
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Idarucizumab
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Trevogrumab
Monoclonal antibody designed to treat X-linked hypophosphatemia
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Burosumab
Monoclonal antibody protein
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Gantenerumab
Chemical compound
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Tanezumab
Medication used for the treatment of migraine headaches
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Rizatriptan
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Abelacimab
Drug used to reduce frequency of headaches
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Pizotifen
Veterinary medication
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Izenivetmab
Chemical compound in the ergot family of alkaloids
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Ergotamine
Management of neurological disorder
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Management_of_migraine
Anti-tau monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Semorinemab
Combination drug
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Amidrine
Monoclonal antibody medication
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Solanezumab
Veterinary medication
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Relfovetmab
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Dihydroergocryptine
Class of pharmaceutical drugs
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Triptan
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Eletriptan
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Methylergometrine
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Avitriptan
MK-3207 Olcegepant Rimegepant SB-268262 Telcagepant Ubrogepant Antibodies: Eptinezumab Erenumab Fremanezumab Galcanezumab Agonists: Cholecystokinin Antagonists:
List of signaling peptide/protein receptor modulators
List_of_signaling_peptide/protein_receptor_modulators
Medication used in treatment of migraines
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Zolmitriptan
Medication intended to reduce the effects or intensity of migraine headache
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Antimigraine_drug
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Lisuride
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Stamulumab
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Inclacumab
Chemical used to treat migraines
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Dihydroergotamine
Antimigraine agent
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Alpiropride
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Lomerizine
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Telcagepant
Chemical compound
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Bococizumab
Antibody tested against Alzheimer's
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Crenezumab
Pharmaceutical compound
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Amlenetug
Medication for macular degeneration
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Faricimab
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
BOL-148
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Frovatriptan
Chemical compound
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Blosozumab
Pharmaceutical drug
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Brolucizumab
Experimental monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Cinpanemab
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Enoticumab
Medication
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Bentracimab
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Icrucumab
Pharmaceutical drug
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Ramucirumab
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Refanezumab
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Methysergide
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Ozanezumab
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Donitriptan
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Iprazochrome
Monoclonal antibody
Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab
Vanucizumab
Chemical compound
Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant
Lasmiditan
EPTINEZUMAB
EPTINEZUMAB
EPTINEZUMAB
EPTINEZUMAB
Female
African
we give thanks.
Girl/Female
Tamil
Flute, Name of Radha Rani
Girl/Female
Tamil
Priyamada | பà¯à®°à¯€à®¯à®¾à®®à®¾à®³à®¾
Boy/Male
Arabic, Muslim, Sindhi
Sacred; Chastity
Girl/Female
Tamil
Beautiful, Embodied, Nature
Boy/Male
Hindu
Distinguished
Boy/Male
Hindu
Light or happiness
Boy/Male
Indian, Sanskrit
Well Fixed
Boy/Male
Polynesian
He laughs.
Boy/Male
Hindu, Indian, Marathi
Half Shiva and Half Vishnu
EPTINEZUMAB
EPTINEZUMAB
EPTINEZUMAB
EPTINEZUMAB
EPTINEZUMAB